Becker's ASC Review
14 healthcare thought leaders on President Trump's executive order on the ACA – 01/24/17
On Jan. 20, President Trump signed an executive order to lessen the economic burden on the ACA. Fourteen healthcare leaders and professionals weighed in on how they think this will impact the industry. One of these such though leaders was Joel Shalowitz, professor of executive education at Kellogg. "I view the executive order as more of a general policy statement than an instrument of actual change. Congressional action is required to repeal or amend the ACA and the regulations related to it require a statutory comment period. It is a 'shot over the bow' that says the new president is serious about his repeal agenda," Shalowitz said.
Poets & Quants
Poets & Quants’ Top MBA Startups Of 2017 – 01/23/17
Article highlights the publication’s top 100 MBA startups of 2017, noting that Kellogg has doubled its representation of startups year-over-year, from four to eight. Additional coverage on the best business schools for MBA startups, also citing Kellogg, is published here.
MBA Crystal Ball
How business schools bring innovation to their classrooms – 01/16/17
Northwestern University’s Kellogg School of Management has evolved a set of seven courses on the “growth and scaling” topic. Rather than evolving a curriculum on a topic and hoping that adjustments would eventually be made on the basis of market feedback, Kellogg went to MBA employers first to understand the business challenges in the area of growth and scaling before evolving the curriculum. MBA Crystal Ball reached out to Benjamin F. Jones, Faculty Director, Kellogg Innovation and Entrepreneurship Initiative, to find out more about how the program change was conceptualized.
It’s the Drug Industry’s Turn to Tremble Before Trump – 01/12/17
Article explains how U.S. taxpayers and patients essentially subsidize the drug industry, yet there is a huge payoff for the system, quoting Professor Craig Garthwaite on how subsidies have also made the U.S. a cradle of biopharmaceutical innovation. “As a country, I don’t think we’re really there yet that we want some of these innovations to not be available to people.”
Cubs strike long-term deal with Beam Suntory – 01/12/17
Article discusses the Chicago Cubs’ new long term deal with spirits giant Beam Suntory, quoting Professor Tim Calkins on how such marketing deals generally don't boost sales right away but are considered longer-term investments to build and change perceptions about brands.
ABC, ‘Black-ish’ Home, Says Diversity Includes Trump Backers – 01/11/17
Article examines how Channing Dungey, the first African-American to lead entertainment at one of the Big Four television networks, is retooling ABC’s programming lineup to include more shows that appeal to rural America, men and lower-income families, quoting Professor Tim Calkins on how casting a wider net to attract more consumers could be a smart business decision.
The New Yorker
The Trump Era Corporate Boycott – 01/09/17
This article discusses the new challenges companies face today in the Trump political climate. Numerous companies including Pepsi and New Balance have fallen victim to boycotts due to comments that have made about Trump and politics. The article noted that company boycotts have occurred throughout history, however, the boycotts taking place now because of Trump comments are not driven by things relevant to the companies' business practices. The article highlights the work of Professor Brayden King who studied high-profile boycotts between 1990 and 2005 and found that, amongst other findings, "a company's stock price fell, on average, every day that the boycott was in the news."
What Happened to Trump's Oreo Obsession? – 01/06/17
Article discusses how it’s just a matter of time before Mondelez comes back under scrutiny by Trump for sending jobs overseas, quoting Professor Tim Calkins on how Mondelez executives should hope to avoid the glare of Trump’s aggressive Twitter persona.